In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 3B4-2037 Drug Master File in Korea (3B4-2037 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 3B4-2037. The MFDS reviews the 3B4-2037 KDMF as part of the drug registration process and uses the information provided in the 3B4-2037 KDMF to evaluate the safety and efficacy of the drug.
After submitting a 3B4-2037 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 3B4-2037 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 3B4-2037 suppliers with KDMF on PharmaCompass.